Use of sublingual buprenorphine for pain relief in office hysteroscopy

Yu Hung Lin, Jiann Loung Hwang, Lee W. Huang, Heng J. Chen

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

STUDY OBJECTIVE: To assess the efficacy of sublingual buprenorphine in the relief of pain associated with office hysteroscopy. DESIGN: Prospective, randomized study (Canadian Task Force classification I). SETTING: Tertiary medical center. PATIENTS: One hundred sixty-four women referred for office hysteroscopy from September 2003 through March 2004. INTERVENTION: Before hysteroscopy, 80 women received a tablet of buprenorphine (group A), and 84 women received a placebo (group B). Their pain sensations were evaluated on a 10-cm visual analog scale, and they were asked about the adverse reactions and level of satisfaction on the following day. MEASUREMENTS AND MAIN RESULTS: The pain score in group A was 3.3 ± 1.1, which was similar to 3.2 ± 1.3 in group B. The pain scores in subgroups of women also were similar within the same group and between the two groups. Thirty-one women (38.8%) in group A reported adverse reactions, including nausea, vomiting, and drowsiness, while none in group B reported any adverse reactions. CONCLUSION: Office hysteroscopy with a 3.1-mm flexible hysteroscope is a well-tolerated procedure. Sublingual buprenorphine is not helpful in relieving the pain associated with hysteroscopy but is associated with significant adverse reactions.

Original languageEnglish
Pages (from-to)347-350
Number of pages4
JournalJournal of Minimally Invasive Gynecology
Volume12
Issue number4
DOIs
Publication statusPublished - Aug 2005
Externally publishedYes

Fingerprint

Hysteroscopy
Buprenorphine
Pain
Hysteroscopes
Sleep Stages
Advisory Committees
Visual Analog Scale
Nausea
Tablets
Vomiting
Placebos
Prospective Studies

Keywords

  • Analgesia
  • Buprenorphine
  • Hysteroscope

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Use of sublingual buprenorphine for pain relief in office hysteroscopy. / Lin, Yu Hung; Hwang, Jiann Loung; Huang, Lee W.; Chen, Heng J.

In: Journal of Minimally Invasive Gynecology, Vol. 12, No. 4, 08.2005, p. 347-350.

Research output: Contribution to journalArticle

Lin, Yu Hung ; Hwang, Jiann Loung ; Huang, Lee W. ; Chen, Heng J. / Use of sublingual buprenorphine for pain relief in office hysteroscopy. In: Journal of Minimally Invasive Gynecology. 2005 ; Vol. 12, No. 4. pp. 347-350.
@article{475f53351b534ee999540829fc069e84,
title = "Use of sublingual buprenorphine for pain relief in office hysteroscopy",
abstract = "STUDY OBJECTIVE: To assess the efficacy of sublingual buprenorphine in the relief of pain associated with office hysteroscopy. DESIGN: Prospective, randomized study (Canadian Task Force classification I). SETTING: Tertiary medical center. PATIENTS: One hundred sixty-four women referred for office hysteroscopy from September 2003 through March 2004. INTERVENTION: Before hysteroscopy, 80 women received a tablet of buprenorphine (group A), and 84 women received a placebo (group B). Their pain sensations were evaluated on a 10-cm visual analog scale, and they were asked about the adverse reactions and level of satisfaction on the following day. MEASUREMENTS AND MAIN RESULTS: The pain score in group A was 3.3 ± 1.1, which was similar to 3.2 ± 1.3 in group B. The pain scores in subgroups of women also were similar within the same group and between the two groups. Thirty-one women (38.8{\%}) in group A reported adverse reactions, including nausea, vomiting, and drowsiness, while none in group B reported any adverse reactions. CONCLUSION: Office hysteroscopy with a 3.1-mm flexible hysteroscope is a well-tolerated procedure. Sublingual buprenorphine is not helpful in relieving the pain associated with hysteroscopy but is associated with significant adverse reactions.",
keywords = "Analgesia, Buprenorphine, Hysteroscope",
author = "Lin, {Yu Hung} and Hwang, {Jiann Loung} and Huang, {Lee W.} and Chen, {Heng J.}",
year = "2005",
month = "8",
doi = "10.1016/j.jmig.2005.05.013",
language = "English",
volume = "12",
pages = "347--350",
journal = "Journal of Minimally Invasive Gynecology",
issn = "1553-4650",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Use of sublingual buprenorphine for pain relief in office hysteroscopy

AU - Lin, Yu Hung

AU - Hwang, Jiann Loung

AU - Huang, Lee W.

AU - Chen, Heng J.

PY - 2005/8

Y1 - 2005/8

N2 - STUDY OBJECTIVE: To assess the efficacy of sublingual buprenorphine in the relief of pain associated with office hysteroscopy. DESIGN: Prospective, randomized study (Canadian Task Force classification I). SETTING: Tertiary medical center. PATIENTS: One hundred sixty-four women referred for office hysteroscopy from September 2003 through March 2004. INTERVENTION: Before hysteroscopy, 80 women received a tablet of buprenorphine (group A), and 84 women received a placebo (group B). Their pain sensations were evaluated on a 10-cm visual analog scale, and they were asked about the adverse reactions and level of satisfaction on the following day. MEASUREMENTS AND MAIN RESULTS: The pain score in group A was 3.3 ± 1.1, which was similar to 3.2 ± 1.3 in group B. The pain scores in subgroups of women also were similar within the same group and between the two groups. Thirty-one women (38.8%) in group A reported adverse reactions, including nausea, vomiting, and drowsiness, while none in group B reported any adverse reactions. CONCLUSION: Office hysteroscopy with a 3.1-mm flexible hysteroscope is a well-tolerated procedure. Sublingual buprenorphine is not helpful in relieving the pain associated with hysteroscopy but is associated with significant adverse reactions.

AB - STUDY OBJECTIVE: To assess the efficacy of sublingual buprenorphine in the relief of pain associated with office hysteroscopy. DESIGN: Prospective, randomized study (Canadian Task Force classification I). SETTING: Tertiary medical center. PATIENTS: One hundred sixty-four women referred for office hysteroscopy from September 2003 through March 2004. INTERVENTION: Before hysteroscopy, 80 women received a tablet of buprenorphine (group A), and 84 women received a placebo (group B). Their pain sensations were evaluated on a 10-cm visual analog scale, and they were asked about the adverse reactions and level of satisfaction on the following day. MEASUREMENTS AND MAIN RESULTS: The pain score in group A was 3.3 ± 1.1, which was similar to 3.2 ± 1.3 in group B. The pain scores in subgroups of women also were similar within the same group and between the two groups. Thirty-one women (38.8%) in group A reported adverse reactions, including nausea, vomiting, and drowsiness, while none in group B reported any adverse reactions. CONCLUSION: Office hysteroscopy with a 3.1-mm flexible hysteroscope is a well-tolerated procedure. Sublingual buprenorphine is not helpful in relieving the pain associated with hysteroscopy but is associated with significant adverse reactions.

KW - Analgesia

KW - Buprenorphine

KW - Hysteroscope

UR - http://www.scopus.com/inward/record.url?scp=22144449279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144449279&partnerID=8YFLogxK

U2 - 10.1016/j.jmig.2005.05.013

DO - 10.1016/j.jmig.2005.05.013

M3 - Article

C2 - 16036196

AN - SCOPUS:22144449279

VL - 12

SP - 347

EP - 350

JO - Journal of Minimally Invasive Gynecology

JF - Journal of Minimally Invasive Gynecology

SN - 1553-4650

IS - 4

ER -